“Our idea is to enhance the access and affordability for next-generation techniques, meaning molecular diagnostics, genomics, pathology, digital pathology, proteomics, metabolomics, and all that. This is the spirit behind Neuberg Diagnostics. —GSK Velu, PhD, BPharm CEO SUMMARY: India is a nation where 50,000 pathology labs operate to serve the clinical laboratory testing needs of 1.4 […]
India’s Neuberg Diagnostics Expands into U.S. Market
Newsmaker Interview
- By Robert Michel
- > From the Volume XXVIII, No. 11 - August 16, 2021 Issue
- Tags: Andy Bhattacharjee PhD, BioReference Laboratories, Business Standard, cap accreditation, Carlisle Companies, clia certified, dark report, digital pathology, Dr Lal PathLabs, esoteric testing genetic testing, GeneDx, genomics, GSK Velu PhD BPharm, IDEXX lab, Illumina, India, ISO 15189 accreditation, Joe Burns, lab consolidation, LabCorp, Massachusetts General Hospital, metabolomics, Metropolis, MGH, molecular diagnostics, NABL, National Accreditation Board for Testing and Calibration Laboratories, NCGM, Neuberg Centre for Genomic Medicine, Neuberg Diagnostics, next generation sequencing, NGS, pathology lab, pcr, people, PerkinElmer, pharma, polymerase chain reaction, proteomics, Quest Diagnostics, Quintiles, robert michel, South African National Accreditation System, SRL Diagnostics, TDR, Tech Triangle, Unilab
